Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
In December 2019, novel coronavirus (SARS-CoV-2) infected pneumonia occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in Chinese Han population is limited. Our objective is to describe the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in the Chinese Han population. In this case series of 752 patients, the full spectrum of cases is described. Fever was present in 86-90% of the patients. The second most common symptom was cough (49.1-51.0%), fatigue (25.2-27.1%), sputum (20.0-23.1%), and headache (9.8-11.1%). the mortality rate is 4.6% in Wuhan, 1.9% in Beijing, and 0.9% in Shanghai. Our findings showed that the levels of lymphocytes were 0.8(IQR, 0.6-1.1)10 9 /L in Wuhan, 1.0(IQR, 0.7-1.4)10 9 /L in Beijing, and 1.1 (IQR, 0.8-1.5) 10 9 /L in Shanghai before admission to hospitals, respectively, indicating that cellular immune function might relate to the mortality. Based on the reference ranges of normal Chinese Han population and the data of the critically ill patients we have observed, it is recommended that reference ranges of people at high risk of COVID-19 infection are CD3 + lymphocytes below 900 cells/mm 3 , CD4 + lymphocytes below 500 cells/mm 3 , and CD8 + lymphocytes below 300 cells/mm 3 .
Article activity feed
-
SciScore for 10.1101/2020.03.08.20031229: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This case series was approved by the institutional ethics board of Shanghai University of Medicine & Health Sciences and Peking Union Medical College Hospital (#ZS-1830).
Consent: Written informed consent was waived due to the rapid emergence of this infectious disease.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) version 13.0 software (SPSS Inc). SPSSsuggested: (SPSS, RRID:SCR_002865)Statistical Package for the Social Sciencessuggested:…SciScore for 10.1101/2020.03.08.20031229: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: This case series was approved by the institutional ethics board of Shanghai University of Medicine & Health Sciences and Peking Union Medical College Hospital (#ZS-1830).
Consent: Written informed consent was waived due to the rapid emergence of this infectious disease.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) version 13.0 software (SPSS Inc). SPSSsuggested: (SPSS, RRID:SCR_002865)Statistical Package for the Social Sciencessuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-